stockrow
Friday 6 November 2026
Export NEPH’s income statement to Excel — free account
Nephros Inc.
NEPH Healthcare Medical Instruments & Supplies
Nephros Inc.’s revenue for fiscal 2025 (year ended December 2025) was $18.8 million, up 32.7% from fiscal 2024.
- Revenue
- +18.0%
- EPS
- +66.7%
- Free cash flow
- −251.5%
Quarter to September 2026, against a year earlier
2.91
0.18
−5.83%
Follow NEPH
Alert me
Nephros Inc. (NEPH) P/E ratio
As of 5 November 2026, Nephros Inc. (NEPH) trades at a P/E ratio of 18.0×. Over the past ten years it has ranged from 0.0× (March 2025) to 71.4× (June 2025); the current reading is higher than 87% of that period. That is below the Medical Instruments & Supplies industry median of 30.3× and below the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 46.1× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 21.1× | (7.90%) |
| Jun 2026 | 22.9× | (49.40%) |
| Mar 2026 | 45.3× | (1.81%) |
| Dec 2025 | 46.1× | 26.77% |
| 43 more quarters | Free account |
Against its own ten years
Low 0.0×
High 71.4×
Ten-year median
0.0×
Current reading's percentile
87
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| POCI Precision Optics Corp. compare | n/m |
| MLSS Milestone Scientific, Inc. compare | n/m |
| HBIO Harvard Bioscience, Inc. compare | n/m |
| BNGO Bionano Genomics, Inc. compare | n/m |
| RVP Retractable Technologies, Inc. compare | n/m |
| ZTEKF Zentek Ltd. compare | n/m |
| DXR Daxor Corporation compare | 4.0× |
| NEPH Nephros Inc. | 18.0× |
| DAVI Davion Healthcare PLC compare | — |
| Medical Instruments & Supplies industry median | 30.3× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)